STAT Plus: Walgreens shareholders want to know how the retailer manages opioid risks
APSTOCK
The proposal requires the chain to report by June 30 detailing any changes the company has made to corporate governance since 2012 concerning opioid sales.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario